Julian Grünewald, MD, studied medicine in Freiburg, Salamanca, and Paris from 2005-2012.
For his MD thesis on cell migration and polarity, Julian joined the lab of Matias Simons at the University of Freiburg’s Center of Systems Biology, where he received his MD in 2015.
He worked as a resident in the department of internal medicine and nephrology of the Medical Center of the University of Freiburg from 2012-2017.
Subsequently, Julian pursued his postdoctoral work as a research fellow of the DFG (German Research Foundation) in the laboratory of J. Keith Joung at Massachusetts General Hospital and Harvard Medical School from 2017-2022. Julian is focused on the engineering of CRISPR gene editing technologies for both research and therapeutic applications. He received a Career Development Award from the American Society of Gene and Cell Therapy (ASGCT) in 2020 and a Young Investigator Award from the European Society of Gene & Cell Therapy (ESGCT) in 2021. In 2022, Julian joined the Technical University of Munich and the Department of Cardiology at the Klinikum rechts der Isar university hospital as a Rudolf Moessbauer fellow. The Grünewald laboratory develops CRISPR technologies for application in organoid systems and for the treatment of cardiovascular diseases.